Skip to content

King Pharmaceuticals KG General Liability — Year 1

Other product segments

All other lines
57%
International
41.8%
Commercial Auto Liability
11.9%
European Hospital Liability
3.2%

Similar metrics at other companies

CNA Financial logo
CNAGeneral Liability — Year 1
3.4%0.0pp
Old Republic International logo
ORIGeneral Liability — Year 1
4.4%-0.3pp
The Hartford Financial Services Group logo
HIGGeneral Liability — 1st Year
2.4%-0.1pp
CNA Financial logo
CNAGeneral Liability — Year 2
12.1%-0.4pp
CNA Financial logo
CNAGeneral Liability — Year 3
15.5%-0.2pp
CNA Financial logo
CNAGeneral Liability — Year 5
14.5%+0.7pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's general liability — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's general liability — year 1?
King Pharmaceuticals (KG) reported general liability — year 1 of 5.9% in Q4 2025.
What does general liability — year 1 mean?
This metric represents the first year of development for general liability claims, typically used in loss triangle analysis to evaluate early-stage claim frequency and severity. It provides an initial view of underwriting performance for the most recent policy year.